Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease.
Leucine-rich repeat kinase 2 (LRRK2) as a potential therapeutic target in Parkinson's disease.
复制标题
DOI:
10.1016/j.tips.2012.04.001
复制
发表时间:
2012-07
影响因子:
13.8
通讯作者:
Dawson TM
中科院分区:
文献类型:
--
作者:
Lee BD;Dawson VL;Dawson TM
Parkinson’s disease (PD) is caused by the progressive degeneration of dopaminergic neurons in the substantia nigra. Although the etiology for most PD remains elusive, the identification of specific genetic defects in familial cases of PD and the signaling pathways governed by these genes has provided tremendous insight into PD pathogenesis. Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are frequently found in familial and sporadic PD. Although current knowledge regarding the regulatory mechanisms of LRRK2 activation is limited, it is becoming increasingly evident that aberrant kinase activity of the pathologic mutants of LRRK2 is associated with neurodegeneration, suggesting that the kinase activity of LRRK2 is a potential therapeutic target. In addition, LRRK2 inhibitors might provide valuable tools to understand the pathophysiological and physiological roles of LRRK2 as well as the etiology of PD. We discuss here the potential and feasibility of targeting LRRK2 as a therapeutic strategy for PD.
登录
查看更多内容
影响因子:
--
作者:
Bronstein JM;Tagliati M;Alterman RL;Lozano AM;Volkmann J;Stefani A;Horak FB;Okun MS;Foote KD;Krack P;Pahwa R;Henderson JM;Hariz MI;Bakay RA;Rezai A;Marks WJ Jr;Moro E;Vitek JL;Weaver FM;Gross RE;DeLong MR
通讯作者:
DeLong MR
影响因子:
11.2
作者:
Biskup, Saskia;Moore, Darren J.;Dawson, Valina L.
通讯作者:
Dawson, Valina L.
影响因子:
4.8
作者:
Greggio, Elisa;Zambrano, Ibardo;Cookson, Mark R.
通讯作者:
Cookson, Mark R.
影响因子:
6.1
作者:
Greggio, Elisa;Jain, Shushant;Cookson, Mark R.
通讯作者:
Cookson, Mark R.
影响因子:
5.3
作者:
Dusonchet, Julien;Kochubey, Olexiy;Aebischer, Patrick
通讯作者:
Aebischer, Patrick